Archived Newsletters

  1. 06.24.25 -- A Psychedelic Path To CDMO Selection? 6/24/2025
    06/24/25 Outsourced Pharma Newsletter
  2. 06.23.25 -- STREAM Edition: Drug Development Outsourcing: The Devil Is In The Details 6/23/2025

    06/23/25 Outsourced Pharma Newsletter

  3. 06.23.25 -- Is An Outsourced BD Model Gaining Traction At CDMOs? 6/23/2025
    06/23/25 Outsourced Pharma Newsletter
  4. 06.20.25 -- Late-Stage Formulation Is A Different Ballgame. Insights From An Allstar 6/20/2025
    06/20/25 Outsourced Pharma Newsletter
  5. 06.19.25 -- A Psychedelic Path To CDMO Selection? 6/19/2025
    06/19/25 Outsourced Pharma Newsletter
  6. 06.18.25 -- Your helping hand in filtration for high concentration drugs. 6/18/2025

    06/18/25 Outsourced Pharma Newsletter

  7. 06.18.25 -- How A Biotech Navigates The CDMO Frenzy For GLP-1 Services 6/18/2025
    06/18/25 Outsourced Pharma Newsletter
  8. 06.17.25 -- Eliminate Scale-Up Surprises: CMC Insights For Every Phase 6/17/2025

    06/17/25 Outsourced Pharma Newsletter

  9. 06.17.25 -- What Biotechs Learn From Takeda's Internal Manufacturing Competition 6/17/2025
    06/17/25 Outsourced Pharma Newsletter
  10. 06.16.25 -- STREAM Edition: You Need 'Brutal Honesty' When Outsourcing 6/16/2025

    06/16/25 Outsourced Pharma Newsletter